Will Moderna’s Tenure on the S&P 500 Index Be Short-Lived?

·5 min read

Moderna (NASDAQ: MRNA) is now officially a member of the S&P 500. In this Motley Fool Live video recorded on July 21, 2021, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss whether or not Moderna's tenure on the S&P 500 index will be short-lived. Let's go over to Moderna, which is now officially, I think today, a member of the S&P 500 Index.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting